Prof. Tramontano has long standing experience in the field of antiviral drug development. Graduate from the University of Cagliari in 1990, he was Visiting Research Scientist at the Department of Pharmacology of Yale University Medical School (CT, USA) in 1990-1992 and 1996-1998. Hired by the University of Cagliari in the 1999, he is Full Professor of Microbiology since 2015 and is currently Chair of the Department of Life and Environmental Sciences. Current research activities are focused on: i) discovery of antiviral agents through techniques for the evaluation of viral enzymatic functions and viral replication in cells; ii) understanding the mechanisms of viral evasion of innate immunity for the development of antiviral agents; iii) identification and characterization of retroviral sequences stably integrated into human genomes and definition of their transcriptome to explore their physiological and pathological role. Prof. Tramontano has been and is scientific coordinator or unit coordinator of research projects granted by the EU, Italian and American national agencies, regional agencies. He has recently collaborated on projects studying drug development of the SARS-CoV-2, HIV-1 and Ebola viruses. He has been invited to give lectures at universities and conferences around the world, as well as chairing numerous scientific meetings.
